Psychiatry

Gamma-hydroxybutyrate to promote slow-wave sleep in major depressive disorder: a randomized crossover trial

by

The Future of Sleep Enhancement: Trends and Innovations Revolutionizing Sleep Quality The quest for better sleep is a global priority, with innovative studies and technological advancements promising to reshape the landscape of sleep medicine. A notable study at the Institute of Pharmacology and Toxicology, University of Zurich, underscores the potential of novel sleep-enhancing interventions like … Read more

LB-102 Significantly Improves Disease Severity in Acute Schizophrenia, with John Kane, MD

by

LB-102: A New Horizon in Schizophrenia Treatment LB Pharmaceuticals has recently unveiled promising data from the NOVA phase 2 study at the 2025 Annual Congress of the Schizophrenia International Research Society. The study evaluated LB-102, a new benzamide antipsychotic, showing significant improvements in disease severity for patients with acute schizophrenia. With mean changes in Clinical … Read more

Cannabis users have elevated dopamine levels associated with psychosis

by

The Emerging Risks of Cannabis Use Disorder on Mental Health A groundbreaking study by McGill University has unveiled a potential biological link between cannabis use disorder (CUD) and elevated dopamine levels in brain regions associated with psychosis. This research could clarify why some cannabis users experience hallucinations and delusions. Understanding Cannabis Use Disorder (CUD) Cannabis … Read more

Expanding Rapid Recovery Close to Home: Robotic-Assisted Joint Replacement Surgery

by

The Rise of Robotic-Assisted Joint Replacement Surgery As technology advances, robotic-assisted joint replacement surgery is becoming a game-changer in the healthcare industry. These cutting-edge procedures promise higher accuracy, less invasive processes, reduced recovery times, and lower complication risks. The AHN Orthopaedic Institute in western Pennsylvania is at the forefront of this movement, providing same-day surgery … Read more

Lower LDL cholesterol linked to reduced dementia risk

by

The Intersection of Cholesterol Management and Dementia Prevention Recent studies continue to reveal intriguing connections between cholesterol management and dementia prevention. Amid growing concerns about the increasing prevalence of dementia, understanding how low-density lipoprotein cholesterol (LDL-C) levels influence cognitive health is pivotal. The latest research, published in the Journal of Neurology, Neurosurgery & Psychiatry, provides … Read more

Rivaroxaban Akin to Warfarin for Left Ventricular Thrombus After MI

by

The Promising Horizon of Anticoagulation: A Look at Rivaroxaban vs. Warfarin Anticoagulants have long played a pivotal role in managing conditions like myocardial infarction (MI) by preventing the formation of dangerous blood clots in the heart. The recent RIVAWAR trial sheds new light on rivaroxaban as a significant contender against warfarin, a standard treatment in … Read more

Intensive Medical Therapy Does Not Improve Outcomes in Women with INOCA

by

The WARRIOR Trial: A Landmark Study in Women’s Heart Health The recent conclusion of the WARRIOR trial has turned heads in the medical community, particularly among specialists treating ischemia without obstructive coronary artery disease (INOCA). Conducted as the largest randomized, pragmatic outcome trial for INOCA, the study has provided critical insights yet with a nuance … Read more

Prior Oral Anticoagulant Use May Influence Stroke, Bleeding Risk in AF

by

Exploring the Future of Anticoagulant Treatments for Atrial Fibrillation New Insights from OCEANIC-AF Study The recent findings from the Oral Factor 11a Inhibitor Asundexian as Novel Antithrombotic–Atrial Fibrillation (OCEANIC-AF) study opened up new possibilities in treating atrial fibrillation (AF) patients. Atrial fibrillation is a common heart condition led by irregular heartbeats, increasing the risk of … Read more

Novel Lipid Indicator Identifies Risk of Ischemic Heart Disease in T2D

by

Unlocking the Future of Lipid Management in Type 2 Diabetes A groundbreaking investigation has unveiled a potential game-changer in assessing ischemic heart disease (IHD) risks for individuals with type 2 diabetes (T2D): the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR). Led by Sikun Zhang of the Second Xiangya Hospital, this study highlights how … Read more

HCPLive 5 Stories in Under 5: Week of 03/16

by

Future Trends in Healthcare: Insights from Recent Developments Advancements in Migraine Treatment Protocols The recent update from the American College of Physicians (ACP) on adding a triptan to NSAIDs or acetaminophen for treating migraines marks a significant shift in acute migraine management. This combination therapy approach could influence new treatment algorithms across healthcare systems. Clinicians, … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]